3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
13
Completed
8
Unknown
5
Terminated
3
Active not recruiting
3
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
10
CNS
8
Thoracic
7
Head & Neck
6
Breast
5
Other hematologic neoplasm
4
Lymphoid
3
Gynecologic
3
Genitourinary
3
Other solid neoplasm
2
Sarcoma
1
Other neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Sarcoma
1
Neoplasms
1
Interventions
Doxorubicin
5
Cyclophosphamide
4
Vincristine
3
Temozolomide
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Injections
3
polatuzumab vedotin
2
liposomal doxorubicin
2
glofitamab
2
envafolimab
2
anlotinib
2
X-Rays
2
Radiotherapy
2
Prednisone
2
Nivolumab
2
Imatinib Mesylate
2
Biopsy
2
AZD 6244
2
toripalimab
1
surufatinib
1
relmacabtagene autoleucel
1
regorafenib
1
pemigatinib
1
pazopanib
1
obinutuzumab
1
montelukast
1
irinotecan sucrosofate
1
fludarabine
1
eribulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Blood Specimen Collection
×
Sarcoma
×
Clear all
NCT07401355
2026-02-10
LIGHT-CTC
Centre Leon Berard
Phase NA
Not yet recruiting
100 enrolled